A registered nonprofit organization advancing evidence-based healthcare policy through expert Health Technology Assessment, Pharmacoeconomic Modeling, and Statistical Analysis.
Pharma Org is dedicated to advancing healthcare decision-making in the Middle East and beyond by providing rigorous, evidence-based Health Technology Assessment and Pharmacoeconomic Analysis. We empower health authorities, pharmaceutical organizations, and academic institutions with the analytical tools and expert guidance needed to make informed, equitable healthcare policy decisions that improve patient outcomes and optimize resource allocation.
Empowering pharmaceutical companies and health authorities with evidence-based insights for better decision-making.
Comprehensive evidence-based evaluation of health technologies including clinical effectiveness, cost-effectiveness, and societal impact assessments.
Learn More →Advanced economic models including cost-effectiveness analyses, Markov models, decision trees, and budget impact analyses for pharmaceutical interventions.
Learn More →Expert statistical consulting including real-world evidence analysis, epidemiological studies, predictive modeling, and meta-analyses for healthcare research.
Learn More →Strategic guidance on pharmaceutical policy, market access, regulatory affairs, and healthcare system navigation aligned with global standards.
Learn More →We combine international best practices with deep understanding of local healthcare systems to deliver solutions that drive real impact in the Middle East and beyond.
Following ISPOR, NICE, and international HTA guidelines to ensure methodological rigor.
Leveraging enterprise-grade technology for healthcare innovation and research.
Pharma Org is an independent nonprofit initiative supporting the healthcare sector with a focus on health economics, HTA, and evidence-based policy insight.
Healthcare Knowledge & Policy Dialogue
Health Economics & Market Access Insight
Research, Evaluation & Analytical Learning
Let's discuss how our expertise can support your pharmaceutical decision-making and market access goals.